156 related articles for article (PubMed ID: 2865960)
1. [Natural peptides and their analogs. XXXV. Synthesis and properties of [Ala5, Orn9]somatostatin].
Shvachkin IuP; Smirnova AP; Ermak NM; Fedotov VP; Sadovnikova NV
Bioorg Khim; 1985 Aug; 11(8):1026-36. PubMed ID: 2865960
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological actions of prosomatostatin.
Meyers CA; Murphy WA; Redding TW; Coy DH; Schally AV
Proc Natl Acad Sci U S A; 1980 Oct; 77(10):6171-4. PubMed ID: 6108563
[TBL] [Abstract][Full Text] [Related]
3. D-Trp8-somatostatin: an analog of somatostatin more potent than the native molecule.
Rivier J; Brown M; Vale W
Biochem Biophys Res Commun; 1975 Jul; 65(2):746-51. PubMed ID: 1096897
[No Abstract] [Full Text] [Related]
4. Effects of highly potent octapeptide analogs of somatostatin on growth hormone, insulin and glucagon release.
Karashima T; Cai RZ; Schally AV
Life Sci; 1987 Aug; 41(8):1011-9. PubMed ID: 2886886
[TBL] [Abstract][Full Text] [Related]
5. [Biological properties of synthetic somatostatin].
Iudaev NA; Fedotov VP; Komolov IS; Morozova LG; Pluzhnikova GN
Probl Endokrinol (Mosk); 1979; 25(1):75-9. PubMed ID: 368759
[TBL] [Abstract][Full Text] [Related]
6. Somatostatin: analogs with selected biological activities.
Brown M; Rivier J; Vale W
Science; 1977 Jun; 196(4297):1467-9. PubMed ID: 867045
[TBL] [Abstract][Full Text] [Related]
7. [Properties of (Ala5, Orn9)-somatostatin. The inhibition of pancreatic and hypophyseal hormone secretion in cell culture].
Sadovnikova NV; Pluzhnikova GN; Smirnova AP; Ermak NM; Shvachkin IuP
Probl Endokrinol (Mosk); 1986; 32(4):63-6. PubMed ID: 2876420
[TBL] [Abstract][Full Text] [Related]
8. Tyrosylated analogues of somatostatin.
Rivier JE; Brown MR; Vale WW
J Med Chem; 1976 Aug; 19(8):1010-3. PubMed ID: 966246
[TBL] [Abstract][Full Text] [Related]
9. [Phe4]somatostatin: a potent, selective inhibitor of growth hormone release.
Meyers CA; Coy DH; Murphy WA; Redding TW; Arimura A; Schally AV
Proc Natl Acad Sci U S A; 1980 Jan; 77(1):577-9. PubMed ID: 6987657
[TBL] [Abstract][Full Text] [Related]
10. [Effect of C-terminal tetrapeptide cholecystokinin (CCK-4) on the function of the islands of Langerhans and the adenohypophysis].
Fedotov VP; Sadovnikova NV; Gudoshnikov VI; Batrameeva LA; Aleshina LV
Biull Eksp Biol Med; 1984 Jun; 97(6):729-31. PubMed ID: 6146360
[TBL] [Abstract][Full Text] [Related]
11. Somatostatin antagonist analog increases GH, insulin, and glucagon release in the rat.
Fries JL; Murphy WA; Sueiras-Diaz J; Coy DH
Peptides; 1982; 3(5):811-4. PubMed ID: 6129618
[TBL] [Abstract][Full Text] [Related]
12. Conformational modifications of cyclic hexapeptide somatostatin analogs.
Freidinger RM; Perlow DS; Randall WC; Saperstein R; Arison BH; Veber DF
Int J Pept Protein Res; 1984 Feb; 23(2):142-50. PubMed ID: 6142021
[TBL] [Abstract][Full Text] [Related]
13. Dissociation of somatostatin effects. Peptides inhibiting the release of growth hormone but not glucagon or insulin in rats.
Grant N; Clark D; Garsky V; Jaunakais I; McGregor W; Sarantakis D
Life Sci; 1976 Sep; 19(5):629-31. PubMed ID: 957897
[No Abstract] [Full Text] [Related]
14. Relative effects of somatostatin and two somatostatin analogues on the release of insulin, glucagon and growth hormone.
Efendić S; Luft R; Sievertsson H
FEBS Lett; 1975 Oct; 58(1):302-5. PubMed ID: 1225595
[No Abstract] [Full Text] [Related]
15. Somatostatin.
Efendić S; Hökfelt T; Luft R
Adv Metab Disord; 1978; 9():367-424. PubMed ID: 347908
[No Abstract] [Full Text] [Related]
16. Somatostatin analogs which inhibit glucagon and growth hormone more than insulin release.
Meyers C; Arimura A; Gordin A; Fernandez-Durango R; Coy DH; Schally AV; Drouin J; Ferland L; Beaulieu M; Labrie F
Biochem Biophys Res Commun; 1977 Jan; 74(2):630-6. PubMed ID: 836315
[No Abstract] [Full Text] [Related]
17. Stimulation of glucagon release by addition of anti-stomatostatin serum to islets of Langerhans in vitro.
Barden N; Lavoie M; Dupont A; Côté J; Côté JP
Endocrinology; 1977 Aug; 101(2):635-8. PubMed ID: 328268
[TBL] [Abstract][Full Text] [Related]
18. Rapid identification of subtype-selective agonists of the somatostatin receptor through combinatorial chemistry.
Rohrer SP; Birzin ET; Mosley RT; Berk SC; Hutchins SM; Shen DM; Xiong Y; Hayes EC; Parmar RM; Foor F; Mitra SW; Degrado SJ; Shu M; Klopp JM; Cai SJ; Blake A; Chan WW; Pasternak A; Yang L; Patchett AA; Smith RG; Chapman KT; Schaeffer JM
Science; 1998 Oct; 282(5389):737-40. PubMed ID: 9784130
[TBL] [Abstract][Full Text] [Related]
19. Evidence of a paracrine role for pancreatic somatostatin in vivo.
Taborsky GJ
Am J Physiol; 1983 Dec; 245(6):E598-603. PubMed ID: 6140853
[TBL] [Abstract][Full Text] [Related]
20. Regulation of insulin and glucagon secretion from rat pancreatic islets in vitro by somatostatin analogues.
Ludvigsen E; Stridsberg M; Taylor JE; Culler MD; Oberg K; Janson ET; Sandler S
Regul Pept; 2007 Jan; 138(1):1-9. PubMed ID: 16935361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
